Fred Warnick, 73, is the first patient in the world to participate in a drug trial for a rare form of non-Hodgkin’s lymphoma. The results so far have been promising.
Fred Warnick, 73, is the first patient in the world to participate in a drug trial for a rare form of non-Hodgkin’s lymphoma. The results so far have been promising.